Anti-CD20 monoclonal antibodies, low risk of pyoderma gangrenosum

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2025年 / 2043卷 / 1期
关键词：
D O I：
10.1007/s40278-025-75282-z
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1 / 1
相关论文
共 50 条
  • [41] Ofatumumab, a human anti-CD20 monoclonal antibody
    Osterborg, Anders
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (03) : 439 - 449
  • [42] Ofatumumab: a novel monoclonal anti-CD20 antibody
    Lin, Thomas S.
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2010, 3 : 51 - 59
  • [43] INFLUENCE OF HISTONE DEACETYLASE INHIBITORS (HDACI) ON CD20 EXPRESSION AND EFFICACY OF ANTI-CD20 MONOCLONAL ANTIBODIES
    Wanczyk, M.
    Kozikowski, M.
    Dwojak, M.
    Bojarczuk, K.
    Winiarska, M.
    HAEMATOLOGICA, 2013, 98 : 409 - 409
  • [44] Anti-CD20 monoclonal antibody/thalidomideMyeloproliferative disorder in an elderly patient (first report with anti-CD20 monoclonal antibody): case report
    Reactions Weekly, 2001, 855 (1) : 7 - 7
  • [45] Multiple signaling pathways of hexavalent anti-CD20 and hexavalent, bispecific, anti-CD20/CD22 humanized monoclonal antibodies correlate with improved anti-lymphoma properties
    Gupta, Pankaj
    Goldenberg, David
    Chang, Chien-Hsing
    CANCER RESEARCH, 2009, 69
  • [46] Switching from natalizumab to anti-CD20 monoclonal antibodies: optimal timing and safety analysis
    Levin, S.
    Levine, L.
    Vargas, W.
    Straus-Farber, R.
    De Jager, P.
    Riley, C.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 333 - 333
  • [47] Systematic literature review of immunoglobulin trends for anti-CD20 monoclonal antibodies in multiple sclerosis
    Shiv Saidha
    Judith Bell
    Sydney Harold
    Jose Marcano Belisario
    Emma Hawe
    Qiujun Shao
    Kerri Wyse
    Eric M. Maiese
    Neurological Sciences, 2023, 44 : 1515 - 1532
  • [48] Key characteristics of anti-CD20 monoclonal antibodies and clinical implications for multiple sclerosis treatment
    Delgado, Silvia R.
    Faissner, Simon
    Linker, Ralf A.
    Rammohan, Kottil
    JOURNAL OF NEUROLOGY, 2024, 271 (04) : 1515 - 1535
  • [49] New and Old Anti-CD20 Monoclonal Antibodies for Nephrotic Syndrome. Where We Are?
    Basu, Biswanath
    Angeletti, Andrea
    Islam, Bilkish
    Ghiggeri, Gian Marco
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [50] Treatment of multiple sclerosis with Anti-CD20 antibodies
    Barun, Barbara
    Bar-Or, Amit
    CLINICAL IMMUNOLOGY, 2012, 142 (01) : 31 - 37
12345